Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1977 1
1979 2
1980 2
1981 3
1982 2
1983 4
1985 5
1987 3
1988 2
1989 5
1990 4
1991 4
1992 1
1993 2
1994 6
1995 8
1996 12
1997 8
1998 5
1999 5
2000 2
2001 5
2002 2
2003 3
2004 9
2005 7
2006 8
2007 13
2008 12
2009 10
2010 14
2011 17
2012 33
2013 13
2014 7
2015 9
2016 5
2017 9
2018 10
2019 12
2020 11
2021 12
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacogenomic Characterization in Bipolar Spectrum Disorders.
Fortinguerra S, Sorrenti V, Giusti P, Zusso M, Buriani A. Fortinguerra S, et al. Among authors: giusti p. Pharmaceutics. 2019 Dec 21;12(1):13. doi: 10.3390/pharmaceutics12010013. Pharmaceutics. 2019. PMID: 31877761 Free PMC article. Review.
Synaptic Plasticity, Dementia and Alzheimer Disease.
Skaper SD, Facci L, Zusso M, Giusti P. Skaper SD, et al. Among authors: giusti p. CNS Neurol Disord Drug Targets. 2017;16(3):220-233. doi: 10.2174/1871527316666170113120853. CNS Neurol Disord Drug Targets. 2017. PMID: 28088900 Review.
Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons.
Skaper SD, Facci L, Zusso M, Giusti P. Skaper SD, et al. Among authors: giusti p. Neuroscientist. 2017 Oct;23(5):478-498. doi: 10.1177/1073858416687249. Epub 2017 Jan 13. Neuroscientist. 2017. PMID: 29283023 Review.
Dealing with complexity: general discussion.
Afonso C, Barrow MP, Bell NGA, Davies AN, Duca D, Focsa C, Gauchotte-Lindsay C, Giusti P, Godfrey R, Goodacre R, Hawkes JA, Hertkorn N, Jansen JJ, Jones D, Kew W, Le Guennec A, Lubben A, Paša-Tolić L, Rodgers RP, Rüger CP, Schmitt-Kopplin P, Schoenmakers PJ, Sciarrone D, Summerfield S, Uhrín D, van Zelst FHM. Afonso C, et al. Among authors: giusti p. Faraday Discuss. 2019 Aug 15;218(0):138-156. doi: 10.1039/C9FD90055A. Faraday Discuss. 2019. PMID: 31384874 No abstract available.
Current and emerging avenues for Alzheimer's disease drug targets.
Loera-Valencia R, Cedazo-Minguez A, Kenigsberg PA, Page G, Duarte AI, Giusti P, Zusso M, Robert P, Frisoni GB, Cattaneo A, Zille M, Boltze J, Cartier N, Buee L, Johansson G, Winblad B. Loera-Valencia R, et al. Among authors: giusti p. J Intern Med. 2019 Oct;286(4):398-437. doi: 10.1111/joim.12959. Epub 2019 Aug 29. J Intern Med. 2019. PMID: 31286586 Free article. Review.
Alpha-synuclein and Parkinson's disease.
Recchia A, Debetto P, Negro A, Guidolin D, Skaper SD, Giusti P. Recchia A, et al. Among authors: giusti p. FASEB J. 2004 Apr;18(6):617-26. doi: 10.1096/fj.03-0338rev. FASEB J. 2004. PMID: 15054084 Review.
303 results